| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |